Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.005 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.006 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.007 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |